This announcement is a separate document:
浙江海正药业股份有限公司独立董事2023年度述职报告（杨立荣）
Zhejiang Haizheng Pharmaceutical Co., Ltd. Independent Director's 2023 Debriefing Report (Yang Lirong)
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.